Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

2.5K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.5K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

1.0K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K
Vitamins01:30

Vitamins

2.6K
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.6K
Erythropoiesis01:14

Erythropoiesis

5.6K
Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
5.6K
Erythropoiesis01:14

Erythropoiesis

4.0K
4.0K
Disorders of Leukocytes01:27

Disorders of Leukocytes

2.2K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep learning based attention enhanced phylogenetic radial basis function networks (AE-PRBFN) for genomic codon usage classification across species.

Scientific reports·2026
Same author

Regularized regression in ultra-small chemometric datasets: A methodological case study using FTIR spectra of Schiff bases.

PloS one·2026
Same author

Circulating tumor cells and tumor-derived cell-free DNA in cancer management: Clinical evidence, limitations, and future directions.

The International journal of biological markers·2026
Same author

Synthesis, characterization, <i>in-silico</i>, and <i>in-vitro</i> evaluation of 4-amino-<i>N</i>-(4-aminophenyl)benzene sulfonamide derivatives against <i>Naja oxiana</i> 5'-nucleotidases (5'-NT) enzyme.

Future medicinal chemistry·2026
Same author

Nanoencapsulated chrysin protects against cadmium-induced renal tissue injury through modulation of oxidative stress, inflammatory responses, mitochondrial dysfunction, and apoptotic pathways.

Tissue & cell·2026
Same author

Nanoliposomal myricetin attenuates diabetic testicular tissue injury and cellular dysfunction via coordinated modulation of PI3K/AKT/mTOR/SREBP-1c, Nrf2/HO-1, NF-κB, and caspase signaling pathways.

Tissue & cell·2026

Related Experiment Video

Updated: Apr 21, 2026

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.9K

Rare case with megaloblastic anaemia.

Munnaza Saleem, Syed Sajid Hussain Shah, Tahir Mehmood

    Journal of Ayub Medical College, Abbottabad : JAMC
    |November 1, 2014
    PubMed
    Summary
    This summary is machine-generated.

    A rare genetic disorder, Thiamine Responsive Megaloblastic Anaemia, caused a young boy

    More Related Videos

    In Situ Exploration of Murine Megakaryopoiesis using Transmission Electron Microscopy
    08:15

    In Situ Exploration of Murine Megakaryopoiesis using Transmission Electron Microscopy

    Published on: September 8, 2021

    2.4K
    Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
    12:05

    Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

    Published on: November 3, 2018

    10.8K

    Related Experiment Videos

    Last Updated: Apr 21, 2026

    Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
    05:35

    Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

    Published on: January 19, 2024

    1.9K
    In Situ Exploration of Murine Megakaryopoiesis using Transmission Electron Microscopy
    08:15

    In Situ Exploration of Murine Megakaryopoiesis using Transmission Electron Microscopy

    Published on: September 8, 2021

    2.4K
    Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
    12:05

    Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

    Published on: November 3, 2018

    10.8K

    Area of Science:

    • Pediatric Hematology
    • Nutritional Genetics
    • Rare Diseases

    Background:

    • Megaloblastic anemia is a condition characterized by the presence of large, immature red blood cells.
    • Neural hearing loss can be associated with certain types of anemia and metabolic disorders.
    • Early diagnosis and intervention are crucial for managing rare pediatric conditions.

    Observation:

    • A 9-year-old boy presented with a history of pallor and anemia since infancy.
    • The patient also exhibited neural hearing loss.
    • Initial treatment with multivitamins and folic acid showed partial improvement.

    Findings:

    • Diagnostic investigations revealed Thiamine Responsive Megaloblastic Anaemia (TRMA).
    • TRMA is an inherited disorder affecting thiamine metabolism, leading to megaloblastic anemia.
    • This condition is exceptionally rare, particularly in the studied setting.

    Implications:

    • Highlights the importance of considering rare genetic disorders in cases of unexplained anemia and neurological symptoms.
    • Emphasizes the need for specific diagnostic approaches beyond standard vitamin supplementation for certain anemias.
    • Suggests that early identification of TRMA can lead to effective management and prevention of complications.